# US 2016/0250097 A9 · Treatment of inflammation by non-invasive stimulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250097 A9
- Document ID: US20160250097A9
- Status: Published application
- Kind: A9
- Application number: 12/048,114
- Filed: 2008-03-13
- Published: 2016-09-01
- Earliest claimed: 2004-03-25
- Assignees: The Feinstein Institute for Medical Research
- Inventors: Kevin J. Tracey; Howland Shaw Warren; Michael Allen Faltys
- Web page: https://patentgrep.com/patent/US20160250097A9

## CPC

- A61H 23/00: Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms {(apparatus for passive exercising A61H1/00; generating or transmitting mechanical vibrations in general B06B)}
- A61H 39/04: Devices for pressing such points, e.g. Shiatsu {or Acupressure}(Massage or pressure on general areas A61H9/00 - A61H23/00)
- A61H 2205/027: Ears
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)

## Abstract

Described herein are devices, systems and method for treating inflammatory disorders by modulating a subject's inflammatory reflex. The method may include the step of non-invasively stimulating the inflammatory reflex (e.g., the vagus nerve, the splenic nerve, the hepatic nerve, the facial nerve, and the trigeminal nerve) of a subject in a manner which significantly reduces proinflammatory cytokines in the subject and/or provides a therapeutically effective treatment for the subject. Devices for non-invasively stimulating the inflammatory reflex may include a movable tip or actuator that is controlled to mechanically stimulate the ear. The devices may be hand-held or wearable, and may stimulate the cymba conchae region of the subject's ear.

## Claims

### Claim 1

A method of treating an inflammatory disorder, the method comprising:
non-invasively stimulating a subject's inflammatory reflex in a manner that significantly reduces proinflammatory cytokines in the subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises mechanical stimulation of the subject's cymba conchae region of their ear.

### Claim 3 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises stimulation between about 50 and 500 Hz.

### Claim 4 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises stimulation of less than 5 minutes.

### Claim 5 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises stimulation for about 1 minute.

### Claim 6 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises a temporal pattern that does not allow accommodation of mechanoreceptors in the region of stimulation during the stimulation period.

### Claim 7 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation comprises mechanical stimulation of the subject's cymba conchae region of their ear for between about 50 and 500 Hz for about one minute.

### Claim 8 (depends on 1)

The method of claims 1, wherein the non-invasive stimulation is applied to the subject's area innervated by the seventh (facial) cranial nerve or cranial nerve V.

### Claim 9 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation is applied to at least one location selected from the subject's cymba conchae of the ear, or helix of the ear.

### Claim 10 (depends on 1)

The method of claim 1, wherein the non-invasive stimulation is applied to at least one point along the spleen meridian.

### Claim 11 (depends on 1)

The method of claims 1, wherein the inflammatory disorder is selected from the group consisting of appendicitis, peptic ulcer, gastric ulcer, duodenal ulcer, peritonitis, pancreatitis, ulcerative colitis, pseudomembranous colitis, acute colitis, ischemic colitis, diverticulitis, epiglottitis, achalasia, cholangitis, cholecystitits, hepatitis, Crohn's disease, enteritis, Whipple's disease, allergy, anaphylactic shock, immune complex disease, organ ischemia, reperfusion injury, organ necrosis, hay fever, sepsis, septicemia, endotoxic shock, cachexia, hyperpyrexia, eosinophilic granuloma, granulomatosis, sarcoidosis, septic abortion, epididymitis, vaginitis, prostatitis, urethritis, bronchitis, emphysema, rhinitis, pneumonitits, pneumotransmicroscopic silicovolcanoconiosis, alvealitis, bronchiolitis, pharyngitis, pleurisy, sinusitis, influenza, respiratory syncytial virus infection, HIV infection, hepatitis B virus infection, hepatitis C virus infection, disseminated bacteremia, Dengue fever, candidiasis, malaria, filariasis, amebiasis, hydatid cysts, burns, dermatitis, dermatomyositis, sunburn, urticaria, warts, wheals, vasulitis, angiitis, endocarditis, arteritis, atherosclerosis, thrombophlebitis, pericarditis, myocarditis, myocardial ischemia, periarteritis nodosa, rheumatic fever, Alzheimer's disease, coeliac disease, congestive heart failure, adult respiratory distress syndrome, meningitis, encephalitis, multiple sclerosis, cerebral infarction, cerebral embolism, Guillame-Barre syndrome, neuritis, neuralgia, spinal cord injury, paralysis, uveitis, arthritides, arthralgias, osteomyelitis, fasciitis, Paget's disease, gout, periodontal disease, rheumatoid arthritis, synovitis, myasthenia gravis, thyroiditis, systemic lupus erythematosis, Goodpasture's syndrome, Behcet's syndrome, allograft rejection, graft-versus-host disease, Type I diabetes, Type II diabetes, ankylosing spondylitis, Berger's disease, Reiter's syndrome, Hodgkin's disease, ileus, hypertension, irritable bowel syndrome, myocardial infarction, sleeplessness, anxiety and stent trombosis.

### Claim 12 (depends on 1)

The method of claims 1, wherein the inflammatory disorder is rheumatoid arthritis.

### Claim 13

A method of treating an inflammatory disorder, the method comprising:
non-invasively stimulating a subject's ear to stimulate the inflammatory reflex in a manner that significantly reduces the proinflammatory cytokines in the subject.

### Claim 14 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises mechanical stimulation of the subject's cymba conchae region of their ear.

### Claim 15 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises stimulation between about 50 and 500 Hz.

### Claim 16 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises stimulation of less than 5 minutes.

### Claim 17 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises stimulation for about 1 minute.

### Claim 18 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises a temporal pattern that does not allow accommodation of mechanoreceptors in the region of stimulation during the stimulation period.

### Claim 19 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation comprises mechanical stimulation of the subject's cymba conchae region of their ear for between about 50 and 500 Hz for about one minute.

### Claim 20 (depends on 13)

The method of claims 13, wherein the non-invasive stimulation is applied to the subject's area innervated by the seventh (facial) cranial nerve or cranial nerve V.

### Claim 21 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation is applied to at least one location selected from the subject's cymba conchae of the ear, or helix of the ear.

### Claim 22 (depends on 13)

The method of claim 13, wherein the non-invasive stimulation is applied to at least one point along the spleen meridian.

### Claim 23 (depends on 13)

The method of claims 13, wherein the inflammatory disorder is selected from the group consisting of appendicitis, peptic ulcer, gastric ulcer, duodenal ulcer, peritonitis, pancreatitis, ulcerative colitis, pseudomembranous colitis, acute colitis, ischemic colitis, diverticulitis, epiglottitis, achalasia, cholangitis, cholecystitits, hepatitis, Crohn's disease, enteritis, Whipple's disease, allergy, anaphylactic shock, immune complex disease, organ ischemia, reperfusion injury, organ necrosis, hay fever, sepsis, septicemia, endotoxic shock, cachexia, hyperpyrexia, eosinophilic granuloma, granulomatosis, sarcoidosis, septic abortion, epididymitis, vaginitis, prostatitis, urethritis, bronchitis, emphysema, rhinitis, pneumonitits, pneumotransmicroscopic silicovolcanoconiosis, alvealitis, bronchiolitis, pharyngitis, pleurisy, sinusitis, influenza, respiratory syncytial virus infection, HIV infection, hepatitis B virus infection, hepatitis C virus infection, disseminated bacteremia, Dengue fever, candidiasis, malaria, filariasis, amebiasis, hydatid cysts, burns, dermatitis, dermatomyositis, sunburn, urticaria, warts, wheals, vasulitis, angiitis, endocarditis, arteritis, atherosclerosis, thrombophlebitis, pericarditis, myocarditis, myocardial ischemia, periarteritis nodosa, rheumatic fever, Alzheimer's disease, coeliac disease, congestive heart failure, adult respiratory distress syndrome, meningitis, encephalitis, multiple sclerosis, cerebral infarction, cerebral embolism, Guillame-Barre syndrome, neuritis, neuralgia, spinal cord injury, paralysis, uveitis, arthritides, arthralgias, osteomyelitis, fasciitis, Paget's disease, gout, periodontal disease, rheumatoid arthritis, synovitis, myasthenia gravis, thyroiditis, systemic lupus erythematosis, Goodpasture's syndrome, Behcet's syndrome, allograft rejection, graft-versus-host disease, Type I diabetes, Type II diabetes, ankylosing spondylitis, Berger's disease, Reiter's syndrome, Hodgkin's disease, ileus, hypertension, irritable bowel syndrome, myocardial infarction, sleeplessness, anxiety and stent trombosis.

### Claim 24 (depends on 13)

The method of claims 13, wherein the inflammatory disorder is rheumatoid arthritis.

### Claim 25

A method of treating an inflammatory disorder, the method comprising:
mechanically stimulating a subject's ear to stimulate the inflammatory reflex in a manner that significantly reduces the proinflammatory cytokines in the subject.

### Claim 26 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises mechanical stimulation of mechanoreceptors within the subject's cymba conchae region of their ear.

### Claim 27 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises stimulation between about 50 and 500 Hz.

### Claim 28 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises stimulation of less than 5 minutes.

### Claim 29 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises stimulation for about 1 minute.

### Claim 30 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises a temporal pattern that does not allow accommodation of mechanoreceptors in the region of stimulation during the stimulation period.

### Claim 31 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation comprises mechanical stimulation of the subject's cymba conchae region of their ear for between about 50 and 500 Hz for about one minute.

### Claim 32 (depends on 25)

The method of claims 25, wherein the non-invasive stimulation is applied to the subject's area innervated by the seventh (facial) cranial nerve or cranial nerve V.

### Claim 33 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation is applied to at least one location selected from the subject's cymba conchae of the ear, or helix of the ear.

### Claim 34 (depends on 25)

The method of claim 25, wherein the non-invasive stimulation is applied to at least one point along the spleen meridian.

### Claim 35 (depends on 25)

The method of claims 25, wherein the inflammatory disorder is selected from the group consisting of appendicitis, peptic ulcer, gastric ulcer, duodenal ulcer, peritonitis, pancreatitis, ulcerative colitis, pseudomembranous colitis, acute colitis, ischemic colitis, diverticulitis, epiglottitis, achalasia, cholangitis, cholecystitits, hepatitis, Crohn's disease, enteritis, Whipple's disease, allergy, anaphylactic shock, immune complex disease, organ ischemia, reperfusion injury, organ necrosis, hay fever, sepsis, septicemia, endotoxic shock, cachexia, hyperpyrexia, eosinophilic granuloma, granulomatosis, sarcoidosis, septic abortion, epididymitis, vaginitis, prostatitis, urethritis, bronchitis, emphysema, rhinitis, pneumonitits, pneumotransmicroscopic silicovolcanoconiosis, alvealitis, bronchiolitis, pharyngitis, pleurisy, sinusitis, influenza, respiratory syncytial virus infection, HIV infection, hepatitis B virus infection, hepatitis C virus infection, disseminated bacteremia, Dengue fever, candidiasis, malaria, filariasis, amebiasis, hydatid cysts, burns, dermatitis, dermatomyositis, sunburn, urticaria, warts, wheals, vasulitis, angiitis, endocarditis, arteritis, atherosclerosis, thrombophlebitis, pericarditis, myocarditis, myocardial ischemia, periarteritis nodosa, rheumatic fever, Alzheimer's disease, coeliac disease, congestive heart failure, adult respiratory distress syndrome, meningitis, encephalitis, multiple sclerosis, cerebral infarction, cerebral embolism, Guillame-Barre syndrome, neuritis, neuralgia, spinal cord injury, paralysis, uveitis, arthritides, arthralgias, osteomyelitis, fasciitis, Paget's disease, gout, periodontal disease, rheumatoid arthritis, synovitis, myasthenia gravis, thyroiditis, systemic lupus erythematosis, Goodpasture's syndrome, Behcet's syndrome, allograft rejection, graft-versus-host disease, Type I diabetes, Type II diabetes, ankylosing spondylitis, Berger's disease, Reiter's syndrome, Hodgkin's disease, ileus, hypertension, irritable bowel syndrome, myocardial infarction, sleeplessness, anxiety and stent trombosis.

### Claim 36 (depends on 25)

The method of claims 25, wherein the inflammatory disorder is rheumatoid arthritis.

### Claim 37

A method of treating an inflammatory disorder, the method comprising:
mechanically stimulating a subject's cymba conchae region of the ear for less than five minutes in a manner that significantly reduces the proinflammatory cytokines in the subject.

### Claim 38

A device for non-invasively stimulating a subject's inflammatory reflex, the device comprising:
a movable distal tip region configured to mechanically stimulate at least a portion of a subject's ear;
a handle; and
a driver configured to move the distal tip region between about 50 and 500 Hz.

### Claim 39 (depends on 38)

The device of claim 38, further comprising a controller configured to control the driver so that it stimulates for less than 5 minutes.

### Claim 40 (depends on 38)

The device of claim 38, wherein the driver comprises a motor.

### Claim 41 (depends on 38)

The device of claim 38, wherein the driver comprises a voice coil.

### Claim 42 (depends on 38)

The device of claim 38, wherein the distal tip region has a diameter of between about 35 mm and about 8 mm.

### Claim 43 (depends on 38)

The device of claim 38, further comprising a frequency generator in communication with the driver.

### Claim 44

A wearable device for non-invasively stimulating a subject's inflammatory reflex, the device comprising:
an actuator configured to mechanically stimulate a subject's cymba conchae;
a driver configured to move the distal tip region between about 50 and 500 Hz; and
an ear attachment region configured to secure to at least a portion of a subject's ear.

### Claim 45 (depends on 44)

The device of claim 44, further comprising an alert configured to indicate that the device should be worn.

### Claim 46 (depends on 44)

The device of claim 44, further comprising a memory configured to record treatment parameters.

### Claim 47 (depends on 44)

The device of claim 44, further comprising feedback to detect delivery of stimulation.

### Claim 48 (depends on 44)

The device of claim 44, wherein the actuator is selected from the group consisting of: electromagnet, bimorph, piezo crystal, electrostatic actuator, speaker coil, and rotating magnet or mass.

### Claim 49 (depends on 44)

The device of claim 44, further comprising a driver circuit for controlling the amplitude, frequency, and duty cycle of the driver.

### Claim 50 (depends on 44)

The device of claim 44, further comprising a device body including the ear attachment region configured to conform to the subject's ear.

### Claim 51 (depends on 44)

The device of claim 44, further comprising a therapy timer configured to limit the duration of stimulation.

### Claim 52 (depends on 44)

The device of claim 44, further comprising a battery.
